Doxa (DOXA) Stockholm Corporate Finance Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Stockholm Corporate Finance Conference 2025 summary
11 Sep, 2025Management and company background
CEO and project development head introduced, highlighting extensive experience in real estate and project development.
Leadership team has broad expertise in property transactions and management.
Company transitioned from dental to real estate focus in 2021.
Strategic transformation and recent transactions
Shifted from investment and mixed operations to a pure property developer.
Acquired and later divested several properties and non-strategic assets to stabilize finances.
Sold off most assets to focus on core real estate development, especially in Gothenburg.
Project portfolio and focus areas
Main asset is Karlastaden in Gothenburg, with over 100,000 sqm of building rights in a prime location.
Karlatornet, a 74-story tower, and Capella block completed; six more blocks remain for development.
Portfolio includes flexible building rights for residential, office, and commercial use.
Additional projects and building rights in Stockholm, Malmö, Lund, Järfälla, Uppsala, and Trelleborg.
Latest events from Doxa
- Year-end NAV at 1,971.5 MSEK; focus on property investments and ongoing legal risks.DOXA
Q4 202527 Feb 2026 - New strategy, major asset sales, and -75.6 MSEK Q3 loss; NAV/share at SEK 1.61.DOXA
Q3 202524 Oct 2025 - Q2 loss driven by write-downs and VAT payment, offset by major asset sale reducing debt.DOXA
Q2 202517 Jul 2025 - Large Q3 loss driven by Serneke value decline; Doxa pivots to core real estate and project development.DOXA
Q3 202413 Jun 2025 - Strategic divestment and capital raise mark Doxa's shift to focused property ownership.DOXA
Q2 202413 Jun 2025 - Doxa's Q1 2025 marked by restructuring, asset sales, and a sharpened focus on property development.DOXA
Q1 20259 Jun 2025 - Heavy loss in 2024 as asset sales and project development refocus reshape the business.DOXA
Q4 20245 Jun 2025